MOUNJARO has not been analyzed in patients with non-proliferative diabetic retinopathy requiring acute therapy, proliferative diabetic retinopathy, or diabetic macular edema. Patients by using a heritage of diabetic retinopathy needs to be monitored for development of diabetic retinopathy.Their efficacy and basic safety profiles are already founded